EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inosine, AMP, and Vidarabine: Network Pharmacology and LC-MS Reveal Key Bioactive Compounds in Periplaneta americana for Ulcerative Colitis Management

Yue Li, Zheng-Mei Shi, Yong He, Zu-Wei Xi, Yi-Hao Che iD, Hai-Rong Zhao, Cheng-Gui Zhang, Heng Liu, Kong-Fa Hu

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26125446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yue Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Artificial Intelligence and Information Technology, Nanjing University of Chinese Medicine, Nanjing 210023, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Inosine, Adenosine Monophosphate, Periplaneta. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Fund of China, Yunnan Province Young and Middle aged Academic and Technical Leaders Reserve Talent Pro-ject, Yunnan Provincial Education Department Scientific Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a chronic inflammatory bowel disease with unmet therapeutic needs. This study investigates the therapeutic potential of Periplaneta americana L. extract (PAE) and its molecular mechanisms, integrating network pharmacology and experimental validation. Liquid chromatography–mass spectrometry identified 1355 compounds in PAE. Network pharmacology analysis revealed that inosine, vidarabine, and adenosine 5′-monophosphate (AMP) were core components and the core components synergistically regulated key targets and acted on inflammation-related pathways, thereby establishing a multi-target anti-inflammatory regulatory network. In vivo experiments demonstrated that these compounds significantly alleviated colitis symptoms in dextran sulfate sodium-induced mice, as evidenced by reduced disease activity index scores, preserved colonic mucosal architecture, and decreased inflammatory infiltration. Mechanistically, core compounds down-regulated granulocyte-macrophage colony-stimulating factor (GM-CSF), inducible nitric oxide synthase (iNOS)/NOS2, monocyte chemoattractant protein 1 (MCP-1), and transforming growth factor beta 1 (TGF-β1), while they up-regulated interleukin-10 (IL-10) and epidermal growth factor (EGF). Additionally, they activated epidermal growth factor receptor (EGFR)-mediated pathways. Molecular docking analysis revealed that adenosine analogs preferentially bound to A1/A2a receptors, triggering signaling cascades essential for epithelial repair and inflammation resolution. This study established the multi-component, multi-pathway mechanism of PAE in UC, highlighting its dual role in suppressing inflammation and promoting mucosal healing. By bridging traditional herbal use with modern molecular insights, these findings provided a translational foundation for developing PAE-based therapies for UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeInosineAdenosine MonophosphatePeriplanetaPlant ExtractsAnimalsMiceNetwork PharmacologyChromatography, LiquidDextran SulfateMaleDisease Models, AnimalMass SpectrometryMolecular Docking SimulationSignal TransductionLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

Periplaneta americanaadenosine analogsinflammationmucosal repairnetwork pharmacologyulcerative colitis

Substanzen

InosineAdenosine MonophosphateDextran SulfatePlant Extracts

Autor:innen und Institutionen

  • School of Artificial Intelligence and Information Technology, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • Institute of Literature in Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, College of Pharmacy, Dali University, Dali 671000, China.
  • Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor, Nanjing 210023, China.
  • Jiangsu Research Center for Major Health Risk Management and TCM Control Policy, Nanjing University of Chinese Medicine, Nanjing 210023, China.

ORCID-Profile: Yi-Hao Che

Förderung

  • National Natural Science Fund of China
  • Yunnan Province Young and Middle aged Academic and Technical Leaders Reserve Talent Pro-ject
  • Yunnan Provincial Education Department Scientific Research Fund
  • Yunnan Province Young and Middle aged Academic and Technical Leaders Reserve Talent Project

Zitieren

APA

Li, Y., Shi, Z. M., He, Y., Xi, Z. W., Che, Y. H., Zhao, H. R., Zhang, C. G., Liu, H., & Hu, K. F. (2025). Inosine, AMP, and Vidarabine: Network Pharmacology and LC-MS Reveal Key Bioactive Compounds in Periplaneta americana for Ulcerative Colitis Management. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125446

Vancouver

Li Y, Shi ZM, He Y, Xi ZW, Che YH, Zhao HR, et al. Inosine, AMP, and Vidarabine: Network Pharmacology and LC-MS Reveal Key Bioactive Compounds in Periplaneta americana for Ulcerative Colitis Management. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125446

BibTeX
@article{Li2025,
  author = {Li, Yue and Shi, Zheng-Mei and He, Yong and Xi, Zu-Wei and Che, Yi-Hao and Zhao, Hai-Rong and Zhang, Cheng-Gui and Liu, Heng and Hu, Kong-Fa},
  title = {Inosine, AMP, and Vidarabine: Network Pharmacology and LC-MS Reveal Key Bioactive Compounds in Periplaneta americana for Ulcerative Colitis Management},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26125446}
}
Kostenlos starten →